| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
73 Outperform | £277.96M | 17.20 | 12.56% | 3.66% | 97.27% | 25.80% | |
69 Neutral | £126.35M | 13.93 | 8.96% | 2.05% | 10.84% | 113.75% | |
67 Neutral | £1.22B | 7.07 | 10.25% | 3.62% | -8.66% | 553.35% | |
64 Neutral | £223.27M | 15.87 | 20.71% | 3.59% | 20.46% | ― | |
54 Neutral | £1.15B | 19.15 | 9.70% | 2.20% | 7.81% | 22.76% | |
51 Neutral | £150.60M | -6.51 | -9.62% | ― | ― | ― |